Does continuous infusion of N-acetylcysteine reduce liver warm ischaemia-reperfusion injury?
The main protective effect of NAC becomes apparent 5 h after hepatic ischaemic injury.
MFS emerged as an independent predictor of OS in men with BRPC treated with deferred ADT after the development of metastases. MFS may be a reasonable intermediate end point in future clinical trials. This observation requires prospective validation.